Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 2Y Ago
-34.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -41.49% |
| Q2 2025 | -16.21% |
| Q1 2025 | -3.52% |
| Q4 2024 | 10.34% |
| Q3 2024 | 0.93% |
| Q2 2024 | -19.39% |
| Q1 2024 | -0.26% |
| Q4 2023 | -32.21% |
| Q3 2023 | 1.21% |
| Q2 2023 | 14.15% |
| Q1 2023 | -6.49% |
| Q4 2022 | 14.09% |
| Q3 2022 | -4.46% |
| Q2 2022 | 25.52% |
| Q1 2022 | 2.35% |
| Q4 2021 | -37.98% |
| Q3 2021 | 218.14% |
| Q2 2021 | 12.31% |
| Q1 2021 | 0.33% |
| Q4 2020 | 59.62% |
| Q3 2020 | -18.30% |
| Q2 2020 | -37.00% |
| Q1 2020 | 0.00% |